These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26913178)

  • 1. Hypothermia in a patient with Alzheimer's disease receiving a combination therapy with risperidone and pipamperone.
    Kamp D; Paschali M; Supprian T; Lange-Asschenfeldt C
    Ther Adv Psychopharmacol; 2016 Feb; 6(1):55-7. PubMed ID: 26913178
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible Hypothermia in a Drug-naive Inpatient with Alzheimer's Disease Receiving Pipamperone.
    Kamp D; Paschali M; Lange-Asschenfeldt C
    Pharmacopsychiatry; 2016 Sep; 49(5):213-214. PubMed ID: 27111131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypothermia during use of pipamperone].
    Eikenboom HC; Janssens AR; Rosekrans PC; Molendijk W
    Ned Tijdschr Geneeskd; 1997 Feb; 141(6):301-3. PubMed ID: 9148168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dried Blood Spots Combined With Ultra-High-Performance Liquid Chromatography-Mass Spectrometry for the Quantification of the Antipsychotics Risperidone, Aripiprazole, Pipamperone, and Their Major Metabolites.
    Tron C; Kloosterboer SM; van der Nagel BCH; Wijma RA; Dierckx B; Dieleman GC; van Gelder T; Koch BCP
    Ther Drug Monit; 2017 Aug; 39(4):429-440. PubMed ID: 28700523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application.
    Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP
    Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pipamperone and delirium: a preliminary evaluation of its effectiveness in the management of delirium and its subtypes.
    Boettger S; Knöpfel S; Schubert M; Garcia Nuñez D; Plichta MM; Klaghofer R; Jenewein J
    Swiss Med Wkly; 2017; 147():w14471. PubMed ID: 28750419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding.
    Schotte A; Janssen PF; Gommeren W; Luyten WH; Van Gompel P; Lesage AS; De Loore K; Leysen JE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):57-73. PubMed ID: 8935801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic considerations in antipsychotic augmentation strategies: How to combine risperidone with low-potency antipsychotics.
    Paulzen M; Schoretsanitis G; Stegmann B; Hiemke C; Gründer G; Schruers KRJ; Walther S; Lammertz SE; Haen E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():101-106. PubMed ID: 28302501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible long-acting risperidone-induced hypothermia precipitating phenytoin toxicity in an elderly patient.
    Brandon Bookstaver P; Miller AD
    J Clin Pharm Ther; 2011 Jun; 36(3):426-9. PubMed ID: 21545623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothermia in a patient receiving risperidone and paroxetine.
    Al Chekakie MO; Ketz JM; Whinney CM
    J Clin Psychopharmacol; 2006 Jun; 26(3):332-3. PubMed ID: 16702902
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical antipsychotic induced mild hypothermia.
    Brevik A; Farver D
    S D J Med; 2003 Feb; 56(2):67-70. PubMed ID: 12621956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.
    Schneider LS; Tariot PN; Dagerman KS; Davis SM; Hsiao JK; Ismail MS; Lebowitz BD; Lyketsos CG; Ryan JM; Stroup TS; Sultzer DL; Weintraub D; Lieberman JA;
    N Engl J Med; 2006 Oct; 355(15):1525-38. PubMed ID: 17035647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild Hypothermia in a Child with Low-Dose Risperidone.
    Grau K; Plener PL; Gahr M; Denzer C; Freudenmann RW
    Z Kinder Jugendpsychiatr Psychother; 2017 Jul; 45(4):335-337. PubMed ID: 27685194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and quantification of the antipsychotics risperidone, aripiprazole, pipamperone and their major metabolites in plasma using ultra-high performance liquid chromatography-mass spectrometry.
    Wijma RA; van der Nagel BC; Dierckx B; Dieleman GC; Touw DJ; van Gelder T; Koch BC
    Biomed Chromatogr; 2016 Jun; 30(6):794-801. PubMed ID: 26447610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Relapse After Discontinuation of Antipsychotic Treatment in Alzheimer's Disease: The Role of Hallucinations.
    Patel AN; Lee S; Andrews HF; Pelton GH; Schultz SK; Sultzer DL; Mintzer J; de la Pena D; Gupta S; Colon S; Schimming C; Levin B; Devanand DP
    Am J Psychiatry; 2017 Apr; 174(4):362-369. PubMed ID: 27855483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study.
    Rocca P; Marino F; Montemagni C; Perrone D; Bogetto F
    Psychiatry Clin Neurosci; 2007 Dec; 61(6):622-9. PubMed ID: 18081622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of 9-hydroxy risperidone concentrations with risk of switching or discontinuation in the clinical antipsychotic trial of intervention effectiveness-Alzheimer's disease trial.
    Wessels AM; Pollock BG; Anyama NG; Schneider LS; Lieberman JA; Marder SR; Bies RR
    J Clin Psychopharmacol; 2010 Dec; 30(6):683-7. PubMed ID: 21105282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use and Characteristics of Antipsychotic/Methylphenidate Combination Therapy in Children and Adolescents with a Diagnosis of Attention-Deficit/Hyperactivity Disorder.
    Scholle O; Banaschewski T; Enders D; Garbe E; Riedel O
    J Child Adolesc Psychopharmacol; 2018; 28(6):415-422. PubMed ID: 29768038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.